To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 19,992 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 3.58% of the total position.
      344Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 8,001 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 2.17% of the total position.
      124Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 41,377 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 1.83% of the total position.
      133Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Cleared position in Novartis AG by 0 shares, the number of shares held decreased 100% compared to the previous period and now represents 0% of the total position.
      91Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 2,079 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 4.15% of the total position.
      78Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 4,340 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 2.31% of the total position.
      55Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 92,204 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 0.73% of the total position.
      2.26KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 24,920 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 9.57% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 546 shares, the number of shares held decreased 0.81% compared to the previous period and now represents 3.88% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-06 07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 56,966 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 5.82% of the total position.
      14Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed